雌激素受体相互作用蛋白在前列腺癌的发展和治疗耐药性的治疗
1Experimental Urology, Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
The American journal of pathology
|December 17, 2023
概括
前列腺癌内分泌疗法由于雄激素受体 (AR) 突变和联合激活剂活性而面临阻力. 向AR联合激活剂提供了一种克服治疗失败和改善治疗结果的新策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 内分泌学 在内分泌学.
背景情况:
- 前列腺癌的内分泌疗法向雄激素受体 (AR) 信号传导,但受到AR突变和过度表达的限制.
- 同活性剂对AR功能至关重要,它们的表达模式与治疗反应和耐药性有关.
研究的目的:
- 探索AR联合激活剂在前列腺癌内分泌治疗耐药性中的作用.
- 在介导抗性的联合激活剂中识别潜在的治疗点.
主要方法:
- 在治疗敏感和耐药前列腺癌模型中分析协活性剂表达.
- 研究协同激活剂与AR和其他信号通路的相互作用.
主要成果:
- 特定的协活性剂,包括p160家族,p300,CBP,GREB1和GATA2,在前列腺癌中高度表达,并有助于AR激活.
- 同活化剂表达在抗恩扎胺的模型中得到增强,并且可以激活与AR无关的途径,如胰岛素类生长因子信号传递.
- 协活性剂可以预测复发并通过与AR和潜在的葡萄糖皮质体受体相互作用,导致治疗失败.
结论:
- 抗逆转基因辅激剂在前列腺癌内分泌疗法耐药性方面发挥着重要作用.
- 向协作激活剂是一个有前途的战略,以克服耐药性并提高前列腺癌治疗的疗效.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
6.8K
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
